Results 191 to 200 of about 347,205 (251)

Safety and Feasibility of Magnetic Separation‐Based Blood Purification

Advanced NanoBiomed Research, EarlyView.
We present the preclinical biological safety and translational feasibility of a magnetic nanoparticle‐based extracorporeal blood purification platform for removal of disease‐causing blood factors. ISO 10993‐compliant studies and exaggerated worst‐case exposure models demonstrate efficient nanoparticle extraction (≥99.9%), favorable biocompatibility ...
Carlos A. Mora, Laurine Rijsbergen, Jan Waskowski, Gaelle Clermont, Florian Dingreville, Chandrashekara Vishwanath, Rajesh Karunanithi, Alexander Gogos, Jean‐Claude Metzger, Manuel Baumgartner, Joerg C. Schefold, Inge K. Herrmann   +11 more
wiley   +1 more source

Evaluating neoantigen-vaccine responses through mechanistic and model-based frameworks. [PDF]

NPJ Precis Oncol
Ibrahim EIK, Laurén I, Veerman RE, Jönsson S, Ytterberg AJ, Lindqvist A, Mangsbo SM, Friberg LE.   +7 more
europepmc   +1 more source

Nanostructured Deep Eutectic Systems in Healthcare: From Bioactive Solvents to Intelligent Biointerfaces, Wearables, and AI‐Driven Design

Advanced NanoBiomed Research, EarlyView.
Beyond the green solvent paradigm, this review redefines Deep Eutectic Systems (DES) as programmable supramolecular nanoassemblies. We survey their biomedical convergence: stabilizing thermolabile mRNA to enable cold chain‐free logistics, reshaping transdermal microneedle delivery, enabling long‐term wearables via eutectogels, and utilizing Generative ...
Jeesu Moon, Min Seo Kim, Jae‐Seung Lee
wiley   +1 more source

mGem: Progress on the development of conjugate vaccines for <i>Cryptococcus neoformans</i> infections. [PDF]

mBio
Stempinski PR, Rodrigues Dos Santos Junior S, Casadevall A.   +2 more
europepmc   +1 more source

Half a century of pneumococcal vaccination in sickle cell disease: Are we winning the battle or losing immunity? [PDF]

Vaccine
Jamwal S, Omene B, Giri A, Rojas K, Mohanty S, Calhoun C, Krishnamurti L, Montgomery RR, Shaw AC, Andemariam B, Yildirim I.   +10 more
europepmc   +1 more source

Consideration of intersectoral costs and benefits in health economic evaluations of pneumococcal conjugate vaccines: a systematic review. [PDF]

Int J Technol Assess Health Care
Almomani E, Dukuray M, Putten IV, Paulus A, Al-Lahham A, van Mastrigt GAPG.   +5 more
europepmc   +1 more source

Mucosal Delivery of Recombinant SARS-CoV-2 Spike Receptor-Binding Domain Antigen Containing Immune-Stimulating Peptides Induces Protective Immune Responses Against Viral Infection in huACE2 Mice. [PDF]

Vaccines (Basel)
Cho BH, Kim J, Jang YS.
europepmc   +1 more source

The Current Status of Simultaneous Vaccination of Children Aged 0-3 Years - China, 2022-2024. [PDF]

China CDC Wkly
Liu X, Liang Y, Zhang Z, Zhang S, Ye J, Hu R, Cao L, Peng H, Li L, Song Y, Yu W.   +10 more
europepmc   +1 more source

The Role of miRNAs in Chicken Immune Regulation and Prospects for Disease‐Resistant Breeding

Animal Research and One Health, EarlyView.
A schematic workflow illustrating the screening of disease‐resistant miRNAs and the generation of miRNA‐based disease‐resistant chickens via PGC‐mediated germline genome editing. ABSTRACT MicroRNAs (miRNAs) are emerging as pivotal regulators of the immune system, playing a decisive role in shaping disease resistance in chicken.
Qiangzhou Wang, Weiran Wu, Qingqing Cai, Jiaxing Wang, Qi Gao, Muhammad Iftikhar, Yulin Bi, Hao Bai, Lihong Gu, Guobin Chang, Shihao Chen   +10 more
wiley   +1 more source

Residual Disparities in US Adults Hospitalized due to All-Cause Pneumonia Following Implementation of Childhood 13-Valent Pneumococcal Conjugate Vaccine in National Immunization Program. [PDF]

Open Forum Infect Dis
Rozenbaum MH, Averin A, Weycker D, Lapidot R, Miles A, Tort MJ, Peyrani P, Vietri J, Lonshteyn A, Pelton SI.   +9 more
europepmc   +1 more source